Ministers are to investigate the cash shortfall facing biotechnology companies in Britain.

The Department of Trade and Industry has appointed Paul Myners, the chairman of Marks and Spencer, to head a study group that will look at the rules governing pre-emption rights - according to which companies must go to their existing shareholders first when raising new funds.